Preclinical development of CD126 CAR-T cells with broad antitumor activity.

Compared to normal plasma cells and B cells ( n = 7), we observed a trend towards higher CD126 expression on primary myeloma and ALL cells, but this did not reach statistical significance (Supplementary Fig. 1B , C ).

also in 111,027 other papers